The role of COX-2 inhibitors in the treatment of postoperative pain

Journal of Cardiovascular Pharmacology

Volumn 47, Issue SUPPL. 1, 2006, Pages

  Schug, Stephan A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Coxibs; Drug safety; NSAIDs; Parecoxib; Postoperative pain; Valdecoxib

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; KETOROLAC; LOCAL ANESTHETIC AGENT; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PARECOXIB; ROFECOXIB; VALDECOXIB;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BLEEDING; BRONCHOSPASM; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIGESTIVE SYSTEM ULCER; DRUG MECHANISM; DRUG POTENTIATION; FRACTURE HEALING; GASTRODUODENAL ULCER; HUMAN; META ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RISK REDUCTION; SKIN MANIFESTATION; SYSTEMATIC REVIEW; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANALGESIA; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; PAIN, POSTOPERATIVE; RISK FACTORS;

EID: 33750441538     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200605001-00015     Document Type: Article

References (34)

1. Warfield CA, Kahn CH. Acute pain management. Programs in U.S. hospitals and experiences and attitudes among U.S. adults. Anesthesiology. 1995;83:1090-1094.
2. Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534-540.
3. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921-1928.
4. Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85:109-117.
5. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil. 2004;16(Suppl 2):54-60.
6. Closs SJ. Patients' night-time pain, analgesic provision and sleep after surgery. Int J Nurs Stud. 1992;29:381-392.
7. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000;93:1123-1133.
8. Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94:11-15.
9. Kessler W, Kirchhoff C, Reeh PW, et al. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res. 1992;91:467-476.
10. Woolf PC. Recent advances in the pathophysiology of acute pain. Br J Anaesth. 1989;63:139-146.
11. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471-475.
12. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1769.
13. Cheer SM, Goa KL. Parecoxib (parecoxib sodium). Drugs. 2001;61:1133-1141.
14. Barden J, Edwards JE, McQuay HJ, et al. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol. 2003;3:1.
15. Kehlet H, Dahl JB. The value of multimodal or balanced analgesia in postoperative pain treatment. Anesth Analg. 1993;77:1048-1056.
16. Gan TJ, Joshi GP, Zhao SZ, et al. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiol Scand. 2004;48:1194-1207.
17. Zhao SZ, Chung F, Hanna DB, et al. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manage. 2004;28:35-46.
18. Gan TJ, Joshi GP, Viscusi E, et al. Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery. Anesth Analg. 2004;98:1665-1673.
19. Harris SI, Stoltz RR, LeComte D, et al. Parecoxib sodium demonstrates gastrointestinal safety comparable to placebo in healthy subjects. J Clin Gastroenterol. 2004;38:575-580.
20. Stoltz RR, Harris SI, Kuss ME, et al. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. Am J Gastroenterol. 2002;97:65-71.
21. Noveck RJ, Laurent A, Kuss M, et al. Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals: two randomised, controlled trials. Clin Drug Invest. 2001;21:465-476.
22. Moiniche S, Romsing J, Dahl JB, et al. Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg. 2003;96:68-77.
23. Hegi TR, Bombeli T, Seifert B, et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth. 2004;92:523-531.
24. Gerstenfeld LC, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res. 2003;21:670-675.
25. Reuben SS. The effects of non-steroidal anti-inflammatory drugs on spinal fusion. Acute Pain. 2004;6:41-45.
26. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can J Anaesth. 2005;52:506-512.
27. Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am. 2005;87:536-542.
28. Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol. 2003;111:1116-1121.
29. Martin-Garcia C, Hinojosa M, Berges P, et al. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Investig Allergol Clin Immunol. 2003;13:20-25.
30. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol. 2001;108:47-51.
31. Martin-Garcia C, Hinojosa M, Berges P, et al. Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest. 2002;121:1812-1817.
32. Ott E, Nussmeier NA, Duke PC, et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2003;125:1481-1492.
33. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352:1081-1091.
34. Whelton A. Safety of Parecoxib and Valdecoxib in the Treatment of Postoperative Pain Following Coronary Artery Bypass Graft Surgery or Major General Surgery. American College of Cardiology 2005 Annual Scientific Session. Orlando, Florida, 2005.